Skip to content

www.windsorbux.com

Menu
  • Home
  • About Us
    • Windsor Bux
    • Our Values
    • Diversity Inclusion
    • Podcasts
    • Charity
  • Markets
    • VC & PE Portfolio Hiring
    • Pharmaceuticals &
       Biotech
  • Our Services
    • Retained Executive Search
    • Premium Contingent Recruitment
    • Project Management
    • Market intelligence
  • OUR RECRUITMENT EXPERTISE
    • Our Disciplines
    • Regulatory Affairs
    • Technical Operations
  • Contact us
  • Charity
Read more about the article Raj S.Pruthi, M.D. – Season 3, Episode 3

Raj S.Pruthi, M.D. – Season 3, Episode 3

  • Post author:admin
  • Post published:July 13, 2025
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Raj S.Pruthi, M.D. - Season 3, Episode 3 S3 Episode 2 of BioByteas by Windsor Bux welcomes Raj S.Pruthi Shakir Bux is joined by Raj S. Pruthi, Chief Medical…

Continue ReadingRaj S.Pruthi, M.D. – Season 3, Episode 3
Read more about the article Nicole Jones – Season 3, Episode 2

Nicole Jones – Season 3, Episode 2

  • Post author:admin
  • Post published:July 13, 2025
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Nicole Jones - Season 3, Episode 2 S3 Episode 2 of BioByteas by Windsor Bux welcomes Nicole Jones This time we’re joined by Nicole Jones, SPHR, Chief People Officer…

Continue ReadingNicole Jones – Season 3, Episode 2
Read more about the article Gabriel Liberatore – Season 3, EP 1

Gabriel Liberatore – Season 3, EP 1

  • Post author:admin
  • Post published:July 13, 2025
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Gabriel Liberatore - Season 3, EP 1 S3 Episode 1 of BioByteas by Windsor Bux welcomes Gabriel Liberatore Gabriel is a global biotech leader with a track record of…

Continue ReadingGabriel Liberatore – Season 3, EP 1
Read more about the article Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

  • Post author:admin
  • Post published:October 21, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsS2 Episode 6 of BioByteas by Windsor Bux welcomes Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsIn this episode of BioBytes, host Shak sits…

Continue ReadingShehnaaz Suliman, M.D, CEO at ReCode Therapeutics
Read more about the article Sandy Milligan, MD JD, C-Suite Executive & Board Member

Sandy Milligan, MD JD, C-Suite Executive & Board Member

  • Post author:admin
  • Post published:September 12, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Sandy Milligan, MD JD, C-Suite Executive & Board MemberS2 Episode 5 of BioByteas by Windsor Bux welcomes Sandy Milligan, MD JD, C-Suite Executive & Board Member. PresidentIn this episode of…

Continue ReadingSandy Milligan, MD JD, C-Suite Executive & Board Member
Read more about the article Alex Oshmyansky, MD, PhD, CEO / Co-Founder

Alex Oshmyansky, MD, PhD, CEO / Co-Founder

  • Post author:admin
  • Post published:August 18, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Alex Oshmyansky, MD, PhD, CEO / Co-Founder S2 Episode 4 of BioByteas by Windsor Bux welcomes Alex Oshmyansky, MD, PhD, CEO / Co-Founder Alex Oshmyansky, CEO and founder of…

Continue ReadingAlex Oshmyansky, MD, PhD, CEO / Co-Founder
Read more about the article Derek Adams, CEO & President

Derek Adams, CEO & President

  • Post author:admin
  • Post published:June 25, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Derek Adams, CEO & President S2 Episode 3 of BioByteas by Windsor Bux welcomes Derek Adams, CEO & President Derek Adams, CEO of Stellular Bio, shares his insights and…

Continue ReadingDerek Adams, CEO & President
Read more about the article Jason Cole – CEO & Chair of the Board, SalioGen

Jason Cole – CEO & Chair of the Board, SalioGen

  • Post author:admin
  • Post published:June 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Jason Cole - CEO & Chair of the Board, SalioGen S2 Episode 2 of BioByteas by Windsor Bux welcomes Jason Cole - CEO & Chair of the Board, SalioGen…

Continue ReadingJason Cole – CEO & Chair of the Board, SalioGen
Read more about the article David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund

David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund

  • Post author:admin
  • Post published:June 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast David Donabedian, PhD - Executive Partner, Interim NewCo CEO, Longwood Fund S2 Episode 1 of BioByteas by Windsor Bux welcomes David Donabedian, PhD - Executive Partner David Donabedian, a…

Continue ReadingDavid Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
Read more about the article Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund

Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund

  • Post author:admin
  • Post published:April 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Stephanie Oestreich, PhD, MPA - Managing Director, Myeloma Investment Fund.Episode 8 of BioByteas by Windsor Bux welcomes Stephanie Oestreich, PhD, MPAStephanie Oestreich, Managing Director at Myeloma Investment Fund, shares…

Continue ReadingStephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund
  • 1
  • 2
  • Go to the next page
  • Raj S.Pruthi, M.D. – Season 3, Episode 3July 13, 2025
  • Nicole Jones – Season 3, Episode 2July 13, 2025
  • Gabriel Liberatore – Season 3, EP 1July 13, 2025
  • Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsOctober 21, 2024
  • Sandy Milligan, MD JD, C-Suite Executive & Board MemberSeptember 12, 2024
  • Alex Oshmyansky, MD, PhD, CEO / Co-FounderAugust 18, 2024
  • Derek Adams, CEO & PresidentJune 25, 2024
  • Jason Cole – CEO & Chair of the Board, SalioGenJune 11, 2024
  • David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood FundJune 11, 2024
  • Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment FundApril 11, 2024

Speak to a Consultant Today

Contact Us

Windsor Bux provides first class recruitment services to the Life Sciences sector. We operate internationally across Mid to Senior level appointments on a Premium Permanent Contingent & Executive Search retained base model.

READ MORE >

Useful Links

  • About Us
  • Premium Contingent
    Recruitment
  • Executive Search
  • Market Intelligence
  • Our Disciplines
  • Regulatory Affairs
  • Charity
  • Contact Us

London - HQ

  • + 44 33 0052 1070
  • office@windsorbux.com
  • Windsor Bux
    Westlink House
    981 Great West Road
    TW8 9DN

Windsor

  • + 1 617 982 1810
  • office@windsorbux.com
  • Windsor Bux
    Castle Hill House
    12 Castle Hill
    Windsor
    SL4 1PD

New York

  • + 1 908 845 8010
  • office@windsorbux.com
  • Windsor Bux
    445 Park Avenue Manhattan
    NY 10022 USA

Dubai

  • +971 (0) 4554 7586
  • office@windsorbux.com
  • Windsor Bux
    Grosvenor Business Tower, Office 1409
    Dubai, UAE
© Windsor Bux Limited All rights reserved. | Privacy Policy